论文部分内容阅读
免疫工作者的新理论为严重心脏缺损的婴儿带来福音。从1985年以来LomaLinda大学医学中心新生儿心脏移植总部已对62例患有严重致命性心脏缺陷的婴儿换上了新心脏。其中14例死亡,48例成活,有些活到3～4岁还很健康。该医学中心Bailey医生说,婴儿心脏移植成活率与成人最高成活率相等。出生后即接受新心脏的婴儿需要的免疫抑制剂水平很低,给予环孢菌素和硫唑嘌呤一年,以后再单用小剂量环孢菌素。
The new theory of immune workers brings gospel to babies with severe heart defects. Since 1985, the LomaLinda University Medical Center’s neonatal heart transplant headquarters has replaced 62 newborns with severely lethal heart defects. Of these, 14 died and 48 survived, and some survived to 3-4 years of age and were still healthy. According to Dr. Bailey, the medical center, the survival rate of infant heart transplant is equal to the highest adult survival rate. Infants who receive a new heart after birth require low levels of immunosuppressants, given one year after cyclosporine and azathioprine, and only a small dose of cyclosporin later on.